| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1.34× | 1.34× | 1.53× | 1.67× | 3.32× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.00× | 1.13× | 1.05× | 0.90× | 1.01× | ||
| 0.07× | 0.07× | 0.07× | 0.10× | 0.13× | ||
| 0.61× | 0.61× | 0.67× | 1.18× | −7.39× | ||
| 0.92× | 0.92× | 0.89× | 0.85× | 0.92× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 3.32 | 1.67 | 1.53 | 1.34 | 1.34 | |
| Working Capital Turnover | 1.01 | 0.90 | 1.05 | 1.13 | 1.00 | |
| Asset Turnover | 0.13 | 0.10 | 0.07 | 0.07 | 0.07 | |
| Cash Conversion (CFO/Net Income) | -7.39 | 1.18 | 0.67 | 0.61 | 0.61 | |
| CFO/EBITDA | 0.92 | 0.85 | 0.89 | 0.92 | 0.92 |